PLAQUE PSORIASIS
Clinical trials for PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New psoriasis drug QL2106 goes Head-to-Head with tremfya in major trial
Disease control Not yet recruitingThis study tests a new injection called QL2106 against the approved drug Tremfya for people with moderate to severe plaque psoriasis. About 318 adults will be randomly assigned to receive either QL2106 or Tremfya, and researchers will compare how well each clears skin symptoms af…
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
Could a diabetes drug boost psoriasis treatment in overweight patients?
Disease control Not yet recruitingThis study tests whether adding metformin (a diabetes drug) to secukinumab (a standard psoriasis medication) works better than secukinumab alone for controlling moderate-to-severe plaque psoriasis in overweight or obese Chinese adults. About 186 participants will receive either t…
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Psoriasis drug combo targets skin and cholesterol in one shot
Disease control Not yet recruitingThis study tests whether adding recaticimab to vunakizumab works better than vunakizumab alone for people with moderate to severe plaque psoriasis who also have high cholesterol. About 40 adults aged 18 to 75 will receive either the combination or a placebo injection. The main go…
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE4 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
New psoriasis pill aims to clear skin in major trial
Symptom relief Not yet recruitingThis study tests an experimental drug called HSK47388 in 220 adults with moderate-to-severe plaque psoriasis. Participants will receive either the drug or a placebo for 16 weeks to see if it reduces skin redness, thickness, and scaling. The goal is to find a new treatment option …
Matched conditions: PLAQUE PSORIASIS
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Symptom relief
Last updated May 19, 2026 12:01 UTC